A modified θ projection model for constant load creep curves-II. Application of creep life prediction

To minimize the deviation of the predicted creep curves obtained under constant load conditions by the original θ projection model, a new modified version that can be expressed by $\epsilon ={\theta }_1\left(1-e^{-{\theta }_{2}t}\right)+{\theta }_3\left(e^{{\theta }_4{e}^{{\theta }_5\epsilon }t}-1\right)$, was derived and experimentally validated in our last study. In the present study, the predictive capability of the modified θ projection model was investigated by comparing the simulated and experimentally determined creep curves of K465 and DZ125 superalloys over a range of temperatures and stresses. Furthermore, the linear relationship between creep temperature and initial stress was extended to the 5-parameter model. The results indicated that the modified model could be used as a creep life prediction method, as it described the creep curve shape and resulted in predictions that fall within a specified error interval. Meanwhile, this modified model provides a more accurate way of describing creep curves under constant load conditions. The limitations and future direction of the modified model were also discussed. In addition, this modified θ projection model shows great potential for the evaluation and assessment of the service safety of structural materials used in components governed by creep deformation.     

Synthesis and characterization of W-SBA-15 and W-HMS as supports for HDS

W-modified HMS and SBA-15 mesoporous materials (Si/W molar ratio equal to 40) were synthesized using sodium tungstate as tungsten source. In order to prepare NiW catalysts these mesoporous materials were impregnated with an aqueous solution of nickel salt of 12-tungstophosphoric acid Ni_3/2PW₁₂O₄₀. The synthesized W-HMS, W-SBA-15 materials and NiW catalysts have been characterized by S_BET, XRD, UV–Vis DRS, FT-IR, TPD of NH₃, ²⁹Si MAS NMR, SEM and HRTEM. The influence of these particular supports on catalytic activity of NiW catalysts was studied in the reaction of hydrodesulfurization (HDS) of thiophene. The results from the FT-IR and UV–Vis DR spectroscopy confirm incorporation of W into the HMS and SBA-15 structures. Additionally ²⁹Si MAS NMR measurements revealed relatively stronger effect of W ion incorporation in HMS structure on degree of silica cross-linking as compared to the effect of W ion incorporation in SBA-15 structure. The catalytic study showed that both W-HMS and W-SBA-15 materials modified with W are good supports for NiW catalysts in the HDS reaction of thiophene. The catalysts show lower selectivity for butanes than a reference NiW/γ-Al₂O₃ catalyst leveling of about 10% for chosen experimental conditions.     

Formation of mesoglobules in aqueous media from thermo-sensitive poly(ethoxytriethyleneglycol acrylate)

A series of six poly(ethoxytriethyleneglycol acrylate) (PETEGA) homopolymers were synthesized by atom transfer radical polymerization, reversible addition-fragmentation transfer polymerization, and anionic polymerization in order to cover a molecular weight range from 7,000 to 40,000 Da. The polymers exhibited a lower critical solution temperature (LCST) behavior in water, which was observed by the occurrence of a cloud point (CP) at around 35 °C. The transmittance of visible light versus temperature dependence overlapped during the cooling and the heating cycles, showing almost a complete lack of hysteresis. Moreover, instead of the occurrence of an uncontrolled macroscopic phase separation, stable colloidal aggregates (mesoglobules) of narrow distribution in particle size were formed in water at temperatures above the LCST of PETEGA at 1 g L⁻¹ solutions. The dimensions of the mesoglobules ranged from 91 to 235 nm, and particle size was not influenced by the molecular weight of PETEGA. Temperature changes caused considerable variations of the mesoglobules dimensions, which were smaller at higher temperatures. The addition of an anionic surfactant simultaneously increased the CP values by 4–6 °C and lowered the dimensions of the mesoglobules.     

Integration of solvent extraction and liquid membrane separation: An efficient tool for recovery of bio-active substances from botanicals

An integrated process based on simultaneous solid-liquid extraction and liquid membrane separation is proposed for recovery and isolation of valuable species from botanicals. This integration provides complete exhausting of the solid material even in the case of very low solubility of the specified solute in the extracting solvent. Selectivity of the liquid membrane ensures a preferential transport of the desired solute from the native extract into the strip solution, while the other co-extracted species remain predominantly in the native extract.     

Synthesis and self-association in aqueous media of poly(ethylene oxide)/poly(ethyl glycidyl carbamate) amphiphilic block copolymers

New temperature sensitive AB, ABA, and BAB amphiphilic block copolymers consisting of hydrophilic poly(ethylene oxide) and hydrophobic poly(ethyl glycidyl carbamate) blocks were synthesized by anionic polymerization followed by chemical modification reactions. The self-association of the block copolymers in aqueous media was studied by UV-vis spectroscopy and dynamic and static light scattering. The obtained block copolymers spontaneously form micelles in aqueous media. The critical micellization concentration varied from 0.5 to 4 g/L depending on the copolymer architecture and composition. The influence of the temperature upon the self-association of the block copolymers was investigated. The increase of temperature did not affect the value of the critical micellization concentration, but led to the formation of better defined micelles with narrow size distribution.     

Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors

BACKGROUND: In 1982, the National Surgical Adjuvant Breast and Bowel Project initiated a randomized, double-blinded, placebo-controlled trial (B-14) to determine the effectiveness of adjuvant tamoxifen therapy in patients with primary operable breast cancer who had estrogen receptor-positive tumors and no axillary lymph node involvement. The findings indicated that tamoxifen therapy provided substantial benefit to patients with early stage disease. However, questions arose about how long the observed benefit would persist, about the duration of therapy necessary to maintain maximum benefit, and about the nature and severity of adverse effects from prolonged treatment. PURPOSE: We evaluated the outcome of patients in the B-14 trial through 10 years of follow-up. In addition, the effects of 5 years versus more than 5 years of tamoxifen therapy were compared. METHODS: In the trial, patients were initially assigned to receive either tamoxifen at 20 mg/day (n = 1404) or placebo (n = 1414). Tamoxifen-treated patients who remained disease free after 5 years of therapy were then reassigned to receive either another 5 years of tamoxifen (n = 322) or 5 years of placebo (n = 321). After the study began, another group of patients who met the same protocol eligibility requirements as the randomly assigned patients were registered to receive tamoxifen (n = 1211). Registered patients who were disease free after 5 years of treatment were also randomly assigned to another 5 years of tamoxifen (n = 261) or to 5 years of placebo (n = 249). To compare 5 years with more than 5 years of tamoxifen therapy, data relating to all patients reassigned to an additional 5 years of the drug were combined. Patients who were not reassigned to either tamoxifen or placebo continued to be followed in the study. Survival, disease-free survival, and distant disease-free survival (relating to failure at distant sites) were estimated by use of the Kaplan-Meier method; differences between the treatment groups were assessed by use of the logrank test. The relative risks of failure (with 95% confidence intervals [CIs]) were determined by use of the Cox proportional hazards model. Reported P values are two-sided. RESULTS: Through 10 years of follow-up, a significant advantage in disease-free survival (69% versus 57%, P < .0001; relative risk = 0.66; 95% CI = 0.58-0.74), distant disease-free survival (76% versus 67%, P < .0001; relative risk = 0.70; 95% CI = 0.61-0.81), and survival (80% versus 76%, P = .02; relative risk = 0.84; 95% CI = 0.71-0.99) was found for patients in the group first assigned to receive tamoxifen. The survival benefit extended to those 49 years of age or younger and to those 50 years of age or older. Tamoxifen therapy was associated with a 37% reduction in the incidence of contralateral (opposite) breast cancer (P = .007). Through 4 years after the reassignment of tamoxifen-treated patients to either continued-therapy or placebo groups, advantages in disease-free survival (92% versus 86%, P = .003) and distant disease-free survival (96% versus 90%, P = .01) were found for those who discontinued tamoxifen treatment. Survival was 96% for those who discontinued tamoxifen compared with 94% for those who continued tamoxifen treatment (P = .08). A higher incidence of thromboembolic events was seen in tamoxifen-treated patients (through 5 years, 1.7% versus 0.4%). Except for endometrial cancer, the incidence of second cancers was not increased with tamoxifen therapy. CONCLUSIONS AND IMPLICATIONS: The benefit from 5 years of tamoxifen therapy persists through 10 years of follow-up. No additional advantage is obtained from continuing tamoxifen therapy for more than 5 years.     

太钢新改造的3座AOD转炉投产及其先进的工艺控制技术

太钢3座40tAOD转炉改造后扩容到45t并于2004年4月成功投产,主要采用两步法生产铁素体和奥氏体不锈钢。介绍了该项目的主要特点以及奥钢联AOD技术特点。     

The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s)

Membrane fusion mediated by interaction of the human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein with the human CD4 molecule generally requires that the CD4 be expressed on a human cell. The failure of murine or simian cells expressing human CD4 to form syncytia upon mixing with cells expressing envelope glycoprotein could not be corrected by expression of both molecules at extremely high surface levels using vaccinia virus expression vectors. Video fluorescence microscopic analysis of fluorescent dye transfer between fusing cells indicated that the block occurred at the level of membrane fusion between individual pairs of cells. To gain insight into the basis for this fusion block, we tested the ability of fluorescent probe cells expressing envelope glycoprotein to fuse with transient animal x human hybrid giant cells expressing human CD4. The hybrid giant cells were generated either by low-pH-induced fusion of vaccinia-infected cells or by CD4/HIV-1 envelope glycoprotein-mediated cell fusion. We observed that envelope glycoprotein-expressing probe cells efficiently fused with CD4-expressing animal x human hybrid giant cells, independent of whether the CD4 was originally expressed on the animal or on the human cell. Fusion did not occur with CD4-expressing giant cells derived from animal cells alone. These results indicate that the fusion block is not due to dominant inhibitory components in the animal cell. Rather, they suggest that human cells contain an additional component(s) which, when transferred to the CD4-bearing animal cell, confers the ability to undergo membrane fusion mediated by the HIV-1 envelope glycoprotein.